XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Operations - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING EXPENSES:    
Amortization $ 229,377 $ 229,377
Research and development expenses 33,299,503 17,258,341
Selling, general and administrative expenses 11,551,568 9,765,259
TOTAL OPERATING EXPENSES 45,080,448 27,252,977
LOSS FROM OPERATIONS (45,080,448) (27,252,977)
OTHER EXPENSE (INCOME):    
Change in fair value of derivative liabilities 1,437,481 (3,287,418)
Interest expense 4,300,150 2,162,989
Interest income (562,264) (44,080)
TOTAL OTHER EXPENSE (INCOME), NET 5,175,367 (1,168,509)
NET LOSS (50,255,815) (26,084,468)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (50,255,815) $ (26,084,468)
NET LOSS PER COMMON SHARE    
- Basic $ (1.55) $ (1.06)
- Diluted $ (1.55) $ (1.06)
WEIGHTED AVERAGE NUMBER OF COMMON  SHARES OUTSTANDING    
- Basic 32,483,489 24,662,557
- Diluted 32,483,489 24,662,557
NET LOSS $ (50,255,815) $ (26,084,468)
Other comprehensive income    
Unrealized gain on investments for available-for-sale 176,591
Other comprehensive income 176,591
Comprehensive loss $ (50,079,224) $ (26,084,468)